Visualizing anti-tumor immune responses in vivo

DMM Disease Models and Mechanisms

Volumn 2, Issue 3-4, 2009, Pages 107-110

  Perentes, Jean Y ^a,b   Duda, Dan G ^a   Jain, Rakesh K ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

CANCER RESEARCH; EDITORIAL; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IMMUNOHISTOCHEMISTRY; IMMUNOSUPPRESSIVE TREATMENT; IMMUNOTHERAPY; MICROSCOPY; PRIORITY JOURNAL; TUMOR CELL; ANIMAL; BIOLOGICAL MODEL; CYTOLOGY; DISEASE COURSE; DISEASE MODEL; HUMAN; IMMUNE SYSTEM; IMMUNOLOGY; LYMPHOCYTE ACTIVATION; METHODOLOGY; MOUSE; NEOPLASM; NEOVASCULARIZATION (PATHOLOGY); ONCOLOGY; STROMA CELL;

ANIMALS; DISEASE MODELS, ANIMAL; DISEASE PROGRESSION; HUMANS; IMMUNE SYSTEM; IMMUNOTHERAPY; LYMPHOCYTE ACTIVATION; MEDICAL ONCOLOGY; MICE; MICROSCOPY; MODELS, BIOLOGICAL; NEOPLASMS; NEOVASCULARIZATION, PATHOLOGIC; STROMAL CELLS;

EID: 69149099931     PISSN: 17548403     EISSN: 17548411     Source Type: Journal    
DOI: 10.1242/dmm.001842     Document Type: Editorial

References (16)

1. Ahn, G. O. and Brown, J. M. (2008). Matrix metalloproteinase-9 is required for tumor vasculogenesis but not for angiogenesis: role of bone marrow-derived myelomonocytic cells. Cancer Cell 13, 193-205.
2. Boissonnas, A., Fetler, L., Zeelenberg, I. S., Hugues, S. and Amigorena, S. (2007). In vivo imaging of cytotoxic T cell infiltration and elimination of a solid tumor. J. Exp. Med. 204, 345-356. (Pubitemid 46294550)
3. Breart, B., Lemaitre, F., Celli, S. and Bousso, P. (2008). Two-photon imaging of intratumoral CD8+ T cell cytotoxic activity during adoptive T cell therapy in mice. J. Clin. Invest. 118, 1390-1397.
4. Chiang, E. Y., Hidalgo, A., Chang, J. and Frenette, P. S. (2007). Imaging receptor microdomains on leukocyte subsets in live mice. Nat. Methods 4, 219-222. (Pubitemid 46358870)
5. Condeelis, J. and Pollard, J. W. (2006). Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124, 263-266. (Pubitemid 43121975)
6. Egeblad, M., Ewald, A. J., Askautrud, H. A., Truitt, M. L., Welm, B. E., Bainbridge, E., Peeters, G., Krummel, M. F. and Werb, Z. (2008). Visualizing stromal cell dynamics in different tumor microenvironments by spinning disk confocal microscopy. Dis. Model. Mech. 1, 155-167.
7. Fukumura, D., Xavier, R., Sugiura, T., Chen, Y., Park, E. C., Lu, N., Selig, M., Nielsen, G., Taksir, T., Jain, R. K. et al. (1998). Tumor induction of VEGF promoter activity in stromal cells. Cell 94, 715-725. (Pubitemid 28436004)
8. Hamzah, J., Jugold, M., Kiessling, F., Rigby, P., Manzur, M., Marti, H. H., Rabie, T., Kaden, S., Grone, H. J., Hammerling, G. J. et al. (2008). Vascular normalization in Rgs5-deficient tumours promotes immune destruction. Nature 453, 410-414. (Pubitemid 351693122)
9. Helmlinger, G., Yuan, F., Dellian, M. and Jain, R. K. (1997). Interstitial pH and pO2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med. 3, 177-182. (Pubitemid 27064702)
10. Jain, R. K. (2005). Normalization of tumor vasculature: an emerging concept in antiangiogenic therapy. Science 307, 58-62.
11. Jain, R. K., Munn, L. L. and Fukumura, D. (2002). Dissecting tumour pathophysiology using intravital microscopy. Nat. Rev. Cancer 2, 266-276.
12. Manning, E. A., Ullman, J. G., Leatherman, J. M., Asquith, J. M., Hansen, T. R., Armstrong, T. D., Hicklin, D. J., Jaffee, E. M. and Emens, L. A. (2007). A vascular endothelial growth factor receptor-2 inhibitor enhances antitumor immunity through an immune-based mechanism. Clin. Cancer Res. 13, 3951-3959.
13. Mrass, P., Takano, H., Ng, L. G., Daxini, S., Lasaro, M. O., Iparraguirre, A., Cavanagh, L. L., von Andrian, U. H., Ertl, H. C., Haydon, P. G. et al. (2006). Random migration precedes stable target cell interactions of tumor-infiltrating T cells. J. Exp. Med. 203, 2749-2761. (Pubitemid 44833350)
14. Perentes, J. Y., McKee, T. D., Ley, C. D., Mathiew, H., Dawson, M., Padera, T. P., Munn, L. L., Jain, R. K. and Boucher, Y. (2009). In vivo imaging of extracellular matrix remodeling by tumor-associated fibroblasts. Nat. Methods 6, 143-145.
15. Shojaei, F., Wu, X., Malik, A. K., Zhong, C., Baldwin, M. E., Schanz, S., Fuh, G., Gerber, H. P. and Ferrara, N. (2007). Tumor refractoriness to anti-VEGF treatment is mediated by CD11b+Gr1+ myeloid cells. Nat. Biotechnol. 25, 911-920.
16. Stroh, M., Zimmer, J. P., Duda, D. G., Levchenko, T. S., Cohen, K. S., Brown, E. B., Scadden, D. T., Torchilin, V. P., Bawendi, M. G., Fukumura, D. et al. (2005). Quantum dots spectrally distinguish multiple species within the tumor milieu in vivo. Nat. Med. 11, 678-682. (Pubitemid 40868310)